| Sanofi India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500674 |
NSE Symbol : SANOFI |
P/E(TTM) : 25.17 |
|
ISIN Demat : INE058A01010 |
Div & Yield% : 2.89 |
EPS(TTM) : 160.35 |
|
Book Value(₹) : 339.61 |
Market Cap(₹Cr) : 9,296.29 |
Face Value(₹) : 10.00 |
| Particulars | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,013.20 | 1,996.10 | 2,770.10 | 2,956.60 | 2,901.90 |
| Other Income | 116.30 | 317.60 | 203.50 | 563.60 | 89.80 |
| Stock Adjustments | -60.20 | 283.70 | 11.10 | -43.10 | -57.50 |
| Total Income | 2,069.30 | 2,597.40 | 2,984.70 | 3,477.10 | 2,934.20 |
| EXPENDITURE : | |||||
| Raw Materials | 919.10 | 1,237.20 | 1,200.70 | 1,263.70 | 1,196.10 |
| Power and Fuel Cost | 11.60 | 8.40 | 14.30 | 13.90 | 23.60 |
| Other Manufacturing Expenses | 34.20 | 26.00 | 74.30 | 73.70 | 90.30 |
| Selling and Administration Expenses | 212.10 | 192.70 | 315.70 | 306.90 | 306.80 |
| Miscellaneous Expenses | 82.70 | 47.10 | 65.90 | 58.90 | 95.40 |
| Employee Benefit Expenses | 240.20 | 280.70 | 405.90 | 433.90 | 460.80 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 569.40 | 805.30 | 907.90 | 1,326.10 | 761.20 |
| Interest | 1.50 | 1.70 | 1.70 | 1.80 | 1.80 |
| Gross Profit | 567.90 | 803.60 | 906.20 | 1,324.30 | 759.40 |
| Depreciation | 36.70 | 36.50 | 41.90 | 66.70 | 82.20 |
| Profit Before Tax | 531.20 | 767.10 | 864.30 | 1,257.60 | 677.20 |
| Current Tax | 125.80 | 163.40 | 245.20 | 336.00 | 211.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -8.10 | 0.50 | -1.50 | -22.80 | -11.40 |
| Reported Net Profit | 413.50 | 603.20 | 620.60 | 944.40 | 477.60 |
| Extraordinary Items | -28.77 | 14.00 | 94.55 | 363.33 | -30.63 |
| Adjusted Net Profit | 442.27 | 589.20 | 526.05 | 581.07 | 508.23 |
| Adjustment below Net Profit | -185.00 | -1.30 | 0.50 | -3.30 | -8.80 |
| Profit/Loss Balance carried down | 601.90 | 843.20 | 1,795.10 | 1,694.60 | 2,029.60 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 384.60 | 843.20 | 1,573.00 | 840.60 | 803.80 |
| P & L Balance carried down | 445.80 | 601.90 | 843.20 | 1,795.10 | 1,694.60 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,170.00 | 1,670.00 | 5,700.00 | 4,900.00 | 3,650.00 |
| Dividend Per Share(Rs) | 117.00 | 167.00 | 570.00 | 490.00 | 365.00 |
| Earnings Per Share-Unit Curr | 179.78 | 262.26 | 269.83 | 410.61 | 207.65 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 374.17 | 441.52 | 554.70 | 967.65 | 921.30 |
| Book Value(Adj)-Unit Curr | 374.17 | 441.52 | 554.70 | 967.65 | 921.30 |